BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 29126900)

  • 1. Activity of nucleic acid polymers in rodent models of HBV infection.
    Schöneweis K; Motter N; Roppert PL; Lu M; Wang B; Roehl I; Glebe D; Yang D; Morrey JD; Roggendorf M; Vaillant A
    Antiviral Res; 2018 Jan; 149():26-33. PubMed ID: 29126900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REP 2139: Antiviral Mechanisms and Applications in Achieving Functional Control of HBV and HDV Infection.
    Vaillant A
    ACS Infect Dis; 2019 May; 5(5):675-687. PubMed ID: 30199230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HBsAg secretion by nucleic acid polymers in HepG2.2.15 cells.
    Blanchet M; Sinnathamby V; Vaillant A; Labonté P
    Antiviral Res; 2019 Apr; 164():97-105. PubMed ID: 30771404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the antiviral effects of REP 2139 on the HBV lifecycle in vitro.
    Boulon R; Blanchet M; Lemasson M; Vaillant A; Labonté P
    Antiviral Res; 2020 Nov; 183():104853. PubMed ID: 32585322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infection.
    Bazinet M; Anderson M; Pântea V; Placinta G; Moscalu I; Cebotarescu V; Cojuhari L; Jimbei P; Iarovoi L; Smesnoi V; Musteata T; Jucov A; Dittmer U; Gersch J; Holzmayer V; Kuhns M; Cloherty G; Vaillant A
    Hepatol Commun; 2022 Aug; 6(8):1870-1880. PubMed ID: 35368148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleic Acid Polymers Are Active against Hepatitis Delta Virus Infection
    Beilstein F; Blanchet M; Vaillant A; Sureau C
    J Virol; 2018 Feb; 92(4):. PubMed ID: 29212929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleic acid-based polymers effective against hepatitis B Virus infection in patients don't harbor immunostimulatory properties in primary isolated liver cells.
    Real CI; Werner M; Paul A; Gerken G; Schlaak JF; Vaillant A; Broering R
    Sci Rep; 2017 Mar; 7():43838. PubMed ID: 28272460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-hepatitis B virus activity of wogonin in vitro and in vivo.
    Guo Q; Zhao L; You Q; Yang Y; Gu H; Song G; Lu N; Xin J
    Antiviral Res; 2007 Apr; 74(1):16-24. PubMed ID: 17280723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of hepatitis B viral entry by nucleic acid polymers in HepaRG cells and primary human hepatocytes.
    Guillot C; Martel N; Berby F; Bordes I; Hantz O; Blanchet M; Sureau C; Vaillant A; Chemin I
    PLoS One; 2017; 12(6):e0179697. PubMed ID: 28636622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination Treatment with the Vimentin-Targeting Antibody hzVSF and Tenofovir Suppresses Woodchuck Hepatitis Virus Infection in Woodchucks.
    Korolowicz KE; Suresh M; Li B; Huang X; Yon C; Kallakury BV; Lee KP; Park S; Kim YW; Menne S
    Cells; 2021 Sep; 10(9):. PubMed ID: 34571970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral effect of oral administration of tenofovir disoproxil fumarate in woodchucks with chronic woodchuck hepatitis virus infection.
    Menne S; Cote PJ; Korba BE; Butler SD; George AL; Tochkov IA; Delaney WE; Xiong S; Gerin JL; Tennant BC
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2720-8. PubMed ID: 15980342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonistic Activation of Cytosolic DNA Sensing Receptors in Woodchuck Hepatocyte Cultures and Liver for Inducing Antiviral Effects.
    Suresh M; Li B; Huang X; Korolowicz KE; Murreddu MG; Gudima SO; Menne S
    Front Immunol; 2021; 12():745802. PubMed ID: 34671360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection.
    Al-Mahtab M; Bazinet M; Vaillant A
    PLoS One; 2016; 11(6):e0156667. PubMed ID: 27257978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Antiviral Effect of the Nucleic Acid Polymer REP 2055 against Persistent Duck Hepatitis B Virus Infection.
    Noordeen F; Scougall CA; Grosse A; Qiao Q; Ajilian BB; Reaiche-Miller G; Finnie J; Werner M; Broering R; Schlaak JF; Vaillant A; Jilbert AR
    PLoS One; 2015; 10(11):e0140909. PubMed ID: 26560490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic woodchuck hepatitis virus infection in the Eastern woodchuck (Marmota monax) with nucleoside analogues is predictive of therapy for chronic hepatitis B virus infection in humans.
    Korba BE; Cote P; Hornbuckle W; Tennant BC; Gerin JL
    Hepatology; 2000 May; 31(5):1165-75. PubMed ID: 10796894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of hepatitis B surface antigen quasispecies during REP 2139-Ca therapy in HBeAg-positive chronic HBV infection.
    Usman Z; Mijočević H; Karimzadeh H; Däumer M; Al-Mathab M; Bazinet M; Frishman D; Vaillant A; Roggendorf M
    J Viral Hepat; 2019 Dec; 26(12):1454-1464. PubMed ID: 31323705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-hepatitis B virus activities of α-DDB-FNC, a novel nucleoside-biphenyldicarboxylate compound in cells and ducks, and its anti-immunological liver injury effect in mice.
    Yang Q; Zhao X; Zang L; Fang X; Zhao J; Yang X; Wang Q; Zheng L; Chang J
    Antiviral Res; 2012 Dec; 96(3):333-9. PubMed ID: 23098744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Woodchuck gamma interferon upregulates major histocompatibility complex class I transcription but is unable to deplete woodchuck hepatitis virus replication intermediates and RNAs in persistently infected woodchuck primary hepatocytes.
    Lu M; Lohrengel B; Hilken G; Kemper T; Roggendorf M
    J Virol; 2002 Jan; 76(1):58-67. PubMed ID: 11739671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication of naturally occurring woodchuck hepatitis virus deletion mutants in primary hepatocyte cultures and after transmission to naive woodchucks.
    Lu M; Hilken G; Yang D; Kemper T; Roggendorf M
    J Virol; 2001 Apr; 75(8):3811-8. PubMed ID: 11264370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.